Stereotactic body radiotherapy (SBRT) and hypofractionated conventional radiotherapy led to similar tumor control and survival outcomes at 3 years in patients with peripheral and central stage I ...

Single-fraction SBRT did not significantly improve bone pain compared to conventional RT. Complete response rates were 37% with SBRT versus 25% with 3D conformal RT at 1 month and remained ...

BARCELONA, Spain — Hypofractionated radiotherapy is noninferior to conventional fractionation for the locoregional treatment of early breast cancer, suggested new results of a phase 3 trial. Sofia ...

A large-scale study provides the strongest evidence yet that a shorter, standard-dose course radiation treatment is just as effective as conventional radiotherapy for prostate cancer, without ...

Results from the NRG Oncology RTOG 0631 clinical trial comparing stereotactic vs. conventional radiotherapy for localized vertebral metastases of the spine did not meet its primary endpoint. Data from ...

Please provide your email address to receive an email when new articles are posted on . Survival and recurrence rates appeared similar between patients who received hypofractionation and conventional ...

To test whether dose-escalated single fraction (SF) stereotactic body radiotherapy (SBRT) of 20 Gy to painful bone metastases is superior to conventional SF three-dimensional (3D) conformal ...

SUNNYVALE, Calif.--(BUSINESS WIRE)--IntraOp Medical Corporation announced the world's first Phase II Electron FLASH Trial. It marks the first time a randomized trial will compare FLASH radiotherapy* ...

(Barcelona, Spain September 8, 2025, 10:45 a.m. CEST / UTC +2) ) — A multi-center, randomized phase III trial has found that a three-week hypofractionated radiotherapy (HypoRT) schedule with ...